TGS Stock Recent News
TGS LATEST HEADLINES
Transportadora De Gas Ord B (TGS) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Transportadora De Gas Ord B (TGS) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Low-beta energy stocks like TotalEnergies (TTE), Weatherford (WFRD) and Transportadora (TGS) are likely to provide a hedge against the notorious volatility of the energy sector.
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Transportadora De Gas Sa Ord B (TGS) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
It is imperative to build a portfolio of low-beta stocks to sail through a volatile market. Penumbra (PEN), Trip.com Group (TCOM), Transportadora (TGS) and Vipshop Holdings (VIPS) are poised to gain.
Transportadora De Gas Sa Ord B (TGS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
Does Transportadora De Gas Sa Ord B (TGS) have what it takes to be a top stock pick for momentum investors? Let's find out.
It is imperative to build a portfolio of low-beta stocks to sail through a choppy market. Penumbra (PEN), Lamb Weston (LW), Transportadora (TGS) and Novo Nordisk (NVO) are poised to gain.